Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2026-01-10 @ 10:12 PM
Study NCT ID:
NCT03463551
Status:
UNKNOWN
Last Update Posted:
2018-08-02
First Post:
2018-03-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Perfluorocarbon (ABL-101) Oxygenation for Stroke: Trial With GOLD (Glasgow Oxygen Level Dependent Technology) Imaging Theranostic
Sponsor:
NHS Greater Glasgow and Clyde
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09
Start Date Type:
ESTIMATED
Primary Completion Date:
2019-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-03
Completion Date Type:
ESTIMATED
First Submit Date:
2018-03-06
First Submit QC Date:
None
Study First Post Date:
2018-03-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-01
Last Update Post Date:
2018-08-02
Last Update Post Date Type:
ACTUAL